DIA's 3rd Annual Conference on Drug Discovery and Clinical Development in India: Scientific, Regulatory, and Social Frontiers

This conference will continue to serve as an international and neutral forum to address current solid scientific research in India pertaining to global development of drugs and biologics. Global thought leaders and experts across the pharmaceutical, academia and regulatory agencies will convene to present drug discovery, global clinical research and scientific working groups. Keynote lectures, workshops, and parallel discussion will highlight the conference.

CONFERENCE HIGHLIGHTS

·        Regulatory Strategic Discussion with Global Regulatory Leaders

·        Development of Medical Devices: Global Regulatory Requirements

·        Opportunities for Establishing Globally Centralized Laboratories in India.

·        India’s Patent Laws and their impact on Biopharmaceutical Industry 4 years after Promulgation

·        India vs. ICH Regulatory Framework for Safety Reporting

1) RASHMI BARBHAIYA, PHD

CEO, Managing Director

and Co-founder

Advinus Therapeutics.

2) SURINDER SINGH, MD

Drug Controller General